Berlex is a specialty pharmaceutical company headquartered in New Jersey and the U.S. affiliate of Schering AG Germany, a global company based in Berlin whose history reaches back more than 130 years.
Berlex's singular approach to developing and making specialized medicines already has yielded innovations in treating multiple sclerosis, female health concerns, cancer and in the creation of new diagnostic imaging techniques.
Careers in Pharmacy
Berlex is very proud to sponsor the "Careers in Pharmacy Student Guide Book" because we believe that pharmacists play a critical role in health care.
Press Releases
2006-Dec-11:
Data From Phase III Comparative Study Show Campath(R) Superior to Chlorambucil as a First-line Therapy in B-CLL
2006-Nov-09:
Bayer Outlines New Global R&D Structures; U.S. Pharma Sites and Future Headquarters
2006-Oct-31:
Berlex Oncology Evaluating Combination Therapy for
Common Form of Non-Hodgkin’s Lymphoma
Berlex, Inc. has adopted a Comprehensive Compliance Program in Conformity with California Senate Bill No. 1765, Chapter 927.
Want the opportunity to make an impact? Then Berlex is where you want to be.
Berlex launches a new site for oncology.
Join Berlex
Want the opportunity to make an impact? Then Berlex is where you want to be.
Berlex News
Berlex launches a new site for oncology.
